ArticleEmerging microbes & infections2023

A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariants.

Jimena Pérez-Vargas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.